{
    "clinical_study": {
        "@rank": "36719", 
        "arm_group": [
            {
                "arm_group_label": "Alpha-Bio's GRAFT Natural Bovine Bone", 
                "arm_group_type": "Active Comparator", 
                "description": "two different bone substitutes commonly used in dental procedures."
            }, 
            {
                "arm_group_label": "Bio-Oss xenograft", 
                "arm_group_type": "Active Comparator", 
                "description": "two different bone substitutes commonly used in dental procedures."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the regenerative results of using separately two\n      different xenografts  after two-step sinus floor elevation."
        }, 
        "brief_title": "Sinus Floor Elevation Using Separately Two Different Xenografts - A Prospective Randomized Clinical Trial", 
        "condition": "Posterior Maxilla Edentulous Patients With Insufficient Alveolar Bone Height", 
        "condition_browse": {
            "mesh_term": "Mouth, Edentulous"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients who will present with a moderately or severely atrophic posterior maxilla\n             with 1-6  mm residual alveolar bone .\n\n          2. Men and women over the age of 18 years.\n\n          3. Patient has signed the Informed Consent.\n\n        Exclusion Criteria:\n\n          1. Chronic steroid therapy.\n\n          2. Uncontrolled diabetes.\n\n          3. Cardiovascular disease.\n\n          4. Past irradiation of head and neck.\n\n          5. Maxillary sinus cysts.\n\n          6. Active chronic sinusitis.\n\n          7. Smoking more than ten cigarettes per day during the 3 months preceding this study .\n\n          8. Malignant disease in the 5 years preceding this study.\n\n          9. Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia,\n             granulocytopenia\n\n         10. Disease that compromise the immune system\n\n         11. Psychiatric disorder\n\n         12. Hypersensitivity to titanium, collagen or bovine bone.\n\n         13. Women who are pregnant or nursing.\n\n         14. Patients with non-treated periodontal disease.\n\n         15. Medical and/or general contraindications for intraoral surgical procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781221", 
            "org_study_id": "12-200"
        }, 
        "intervention": [
            {
                "arm_group_label": "Alpha-Bio's GRAFT Natural Bovine Bone", 
                "intervention_name": "Alpha-Bio's GRAFT Natural Bovine Bone", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Bio-Oss xenograft", 
                "intervention_name": "Bio-Oss xenograft", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 29, 2013", 
        "number_of_arms": "2", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Uneventful healing and histological bone formation", 
            "safety_issue": "No", 
            "time_frame": "6 months following sinus floor augmentation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781221"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "X-ray demonstration of volume - stable results", 
                "safety_issue": "No", 
                "time_frame": "6 months following augmentation procedures."
            }, 
            {
                "measure": "Equally high implant survival rates and crestal bone loss", 
                "safety_issue": "No", 
                "time_frame": "After 1,2 years"
            }
        ], 
        "source": "University Hospital of Cologne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital of Cologne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}